Dermapharm Holding SE (DMPHF)
Dermapharm Market Cap : 2.617B for May 8, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Bayer AG | 42.68B |
| Merck KGaA | 57.98B |
| AstraZeneca PLC | 283.57B |
| ANI Pharmaceuticals, Inc. | 1.862B |
| Corcept Therapeutics, Inc. | 5.612B |
Market Cap Related Metrics
| PE Ratio | 17.45 |
| PS Ratio | 1.989 |
| PEG Ratio | 0.8105 |
| Price to Book Value | 3.209 |
| Price to Free Cash Flow | 16.13 |
| Price | 48.60 |
| Earnings Yield | 5.73% |
| PEGY Ratio | 0.7364 |
| Operating PE Ratio | 10.19 |
| Normalized PE Ratio | 16.84 |